Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
STOCKHOLM--(BUSINESS WIRE)--Regulatory News: RaySearch Laboratories AB (STO:RAYB) announces that version 4.0 of RaySearch’s RayStation® treatment planning system has been released for clinical use in several European countries, USA, Japan, Australia and New Zealand, and is scheduled for market release in Canada, China, and South Korea. The new version includes a wide range of new features and improvements. For example, RayStation® contains a unique solution enabling a more efficient treatment planning process called Multi-criteria optimization. This highly intuitive tool lets the clinician evaluate the impact of changing different treatment priorities in real-time, which has a large potential to speed up the time-consuming treatment planning optimization process. With RayStation® 4.0 the tool for Multi-criteria optimization is extended with support for creating VMAT treatments in addition to IMRT. This means that the system stands out as the most intuitive treatment planning system for creating all advanced radiation treatments.
Help employers find you! Check out all the jobs and post your resume.
